Related references
Note: Only part of the references are listed.Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: Results from a noninterventional study
Ludger Klimek et al.
ALLERGY AND ASTHMA PROCEEDINGS (2015)
Ragweed pollen: is climate change creating a new aeroallergen problem in the UK?
C. H. Pashley et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2015)
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
Jean Bousquet et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States
Jonathan I. Silverberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities: a population-based observational study
Simone Accordini et al.
BMC PULMONARY MEDICINE (2015)
A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis
Erminia Ridolo et al.
THERAPEUTIC DELIVERY (2015)
Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review
T. Zuberbier et al.
ALLERGY (2014)
Allergic rhinitis is a risk factor for traffic safety
E. F. P. M. Vuurman et al.
ALLERGY (2014)
Childhood intermittent and persistent rhinitis prevalence and climate and vegetation: a global ecologic analysis
Elaine Fuertes et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
Philippe Devillier et al.
BMC MEDICINE (2014)
Trends in the prevalence of asthma, rhinitis, and eczema in 15 year old adolescents over an 8 year period
Jeong-Lim Kim et al.
RESPIRATORY MEDICINE (2014)
Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis
William E. Berger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
CLINICAL DEVELOPMENT OF AN ADVANCED INTRANASAL DELIVERY SYSTEM OF AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
H. Derendorf et al.
DRUGS OF TODAY (2014)
Airway dysfunction in elite athletes - an occupational lung disease?
O. J. Price et al.
ALLERGY (2013)
Specialist-based treatment reduces the severity of allergic rhinitis
J. Mullol et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
MP29-02: a breakthrough for the treatment of allergic rhinitis
Jonathan A. Bernstein
EXPERT OPINION ON PHARMACOTHERAPY (2013)
MP29-02 for the treatment of seasonal allergic rhinitis: a review of clinical pharmacology, efficacy and safety
William E. Berger
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
Evidence-based treatment options for allergic diseases in otolaryngology
L. Klimek et al.
HNO (2013)
Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care
Philippe Jean Bousquet et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis
Eli Meltzer et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Rising trend of allergic rhinitis prevalence among Turkish schoolchildren
Fatma Duksal et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2013)
Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey
Mark Small et al.
Clinical and Translational Allergy (2013)
Safety of Inhaled Fluticasone Propionate Therapy for Pediatric Asthma A Systematic Review
Prasad Muley et al.
CURRENT DRUG SAFETY (2013)
A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
Anne K. Ellis et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2013)
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety
Eli O. Meltzer et al.
ALLERGY AND ASTHMA PROCEEDINGS (2012)
Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis
Neil Bhattacharyya
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2012)
Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray
Hartmut Derendorf et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study)
C. Colas et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010
R. de Marco et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
The Editors' Choice
Donald Y.M. Leung et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis
Warner Carr et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis
Peter W Hellings et al.
Clinical and Translational Allergy (2012)
Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey
Giorgio Ciprandi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Increased Prevalence of Symptoms of Rhinitis but Not of Asthma between 1990 and 2008 in Swedish Adults: Comparisons of the ECRHS and GA2LEN Surveys
Anders Bjerg et al.
PLOS ONE (2011)
Allergic rhinitis and the common cold - high cost to society
J. Hellgren et al.
ALLERGY (2010)
Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis
Rania Esteitie et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device
Frank C. Hampel et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Uncontrolled allergic rhinitis during treatment and its impact on quality of life: A cluster randomized trial
Philippe J. Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Jan L. Brozek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
The impact of allergic rhinitis on sexual activity, sleep, and fatigue
Michael S. Benninger et al.
ALLERGY AND ASTHMA PROCEEDINGS (2009)
Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo
D. Baumann et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis
Friedrich Horak et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2009)
Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey
Eli O. Meltzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet et al.
ALLERGY (2008)
Combination therapy with azelastine and fluticasone nasal sprays
John M. Kelso
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis
Robert Anolik
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
The voice of the patients: allergic rhinitis is not a trivial disease
Erkka Valovirta et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2008)
The diagnosis and management of rhinitis: An updated practice parameter
Dana V. Wallace et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Patient Perceptions of Allergic Rhinitis and Quality of Life Findings From a Survey Conducted in Europe and the United States
G. Walter Canonica et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2008)
BSACI guidelines for the management of allergic and non-allergic rhinitis
G. K. Scadding et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey
M. Maurer et al.
ALLERGY (2007)
Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case-control study
Samantha Walker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Allergic rhinitis: The impact of discordant perspectives of patient and physician on treatment decisions
Eli O. Meltzer
CLINICAL THERAPEUTICS (2007)
Increase in the prevalence of rhinitis among Danish children from 1986 to 2001
Kare Hakansson et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2007)
The burden of allergic rhinitis
Robert A. Nathan
ALLERGY AND ASTHMA PROCEEDINGS (2007)
Allergic rhinitis and its consequences on quality of sleep -: An unexplored area
Damien Leger et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective
Charles E. Lamb et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being
B Kremer et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Share Paper
